Expert Opinion on Investigational Drugs, Volume 29, Issue 5 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Investigational Drugs, Volume 29, Issue 5 (2020)

See all volumes and issues
Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Volume 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Drug Evaluation

Article
Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease
Sameem M. Abedin & Mehdi Hamadani
Pages: 423-427
Published online: 19 Apr 2020
AbstractforRuxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease | Full Text | References | PDF (451.2 KB) | EPUB
  • 419 Views
  • 7 CrossRef citations
  • 0Altmetric
Article
BIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure
Vijay K. Singh & Thomas M Seed
Pages: 429-441
Published online: 25 May 2020
AbstractforBIO 300: a promising radiation countermeasure under advanced development for acute radiation syndrome and the delayed effects of acute radiation exposure | Full Text | References | PDF (1.1 MB) | EPUB
  • 3447 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Review

New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis
Pablo Villoslada & Lawrence Steinman
Pages: 443-459
Published online: 29 Apr 2020
AbstractforNew targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis | Full Text | References | PDF (1.7 MB) | EPUB
  • 1630 Views
  • 28 CrossRef citations
  • 0Altmetric
Investigational non-JAK inhibitors for chronic phase myelofibrosis
Aniket Bankar & Vikas Gupta
Pages: 461-474
Published online: 29 Apr 2020
AbstractforInvestigational non-JAK inhibitors for chronic phase myelofibrosis | Full Text | References | PDF (1.6 MB) | EPUB
  • 5442 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis
Michael D. Wiese, Arkady T. Manning-Bennett & Ahmad Y. Abuhelwa
Pages: 475-482
Published online: 17 Apr 2020
AbstractforInvestigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis | Full Text | References | PDF (841.9 KB) | EPUB
  • 2802 Views
  • 31 CrossRef citations
  • 0Altmetric
Gene-based therapy in lipid management: the winding road from promise to practice
Tycho R. Tromp, Erik S.G. Stroes & G. Kees Hovingh
Pages: 483-493
Published online: 29 Apr 2020
AbstractforGene-based therapy in lipid management: the winding road from promise to practice | Full Text | References | PDF (988.4 KB) | EPUB
  • 4681 Views
  • 20 CrossRef citations
  • 0Altmetric
Open Access
Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials
Matteo Bassetti, Filippo Del Puente, Laura Magnasco & Daniele Roberto Giacobbe
Pages: 495-506
Published online: 19 Apr 2020
AbstractforInnovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials | Full Text | References | PDF (1 MB) | EPUB
  • 356 Views
  • 13 CrossRef citations
  • 0Altmetric
Experimental drugs for the inhibition of preterm labor
Tegan Triggs, Sailesh Kumar & Murray Mitchell
Pages: 507-523
Published online: 29 Apr 2020
AbstractforExperimental drugs for the inhibition of preterm labor | Full Text | References | PDF (1.5 MB) | EPUB
  • 511 Views
  • 7 CrossRef citations
  • 0Altmetric

Explore articles